Enter your terms above and click the 'Search' button.

Showing articles 0 to 11 of 11 Filter Applied: serum glutamic oxaloacetic transaminase (Click to remove) Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management The Neurologist 8:227-236, Frohman,E.,et al, 2002 Tasmar (tolcapone) Labeling Revisions of Package Insert Roche Laboratories, , 1998 Long-Term Efficacy and Safety of Deprenyl (Selegiline) in Advanced Parkinson's Disease Neurol 39:1109-1111, Golbe,L.I.,et al, 1989 Nonsystemic Vasculitic Mononeuropathy Multiplex, Cryoglobulinemia, and Hepatitis C Muscle & Nerve 19:1596-1602996., David,W.S.,et al, 1996 Diag of Occult Muscular Dystrophy:"Chance"Finding of Elevated Serum Aminotransferase Act J Pediatr 122:254-256, Morse,R.P.&Rosman,N.P., 1993 Diagnosis & Treatment of Reye's Syndrome JAMA 246:2441-2444, Dodge,P.R.,et al, 1981 Adult Toxoplasmosis Presenting as Polymyositis & Cerebellar Ataxia Ann Int Med 82:367, Greenlee,J.,et al, 1975 Acute Hepatic Failure Associated with the Use of Sodium Valproate NEJM 300:962-966, Suchy,F.J.,et al, 1979 Reye's Syndrome in the Adult Patient Am J Med 67:672-678, Atkins,J.N.,et al, 1979 Valproic Acid, Review of a New Antiepileptic Drug Arch Neurol 36:393-398, Bruni,J.,et al, 1979 Effect of Valproic Acid on Hepatic Function Neurol 28:961-964, Willmore,L.J.,et al, 1978 Showing articles 0 to 11 of 11